You need a partner with a proven track record of advancing gene therapy product development and manufacturing, and the ability to adapt to your needs. As your trusted expert in life science, we provide optimized viral vector manufacturing platforms, packaging cell lines, media and reagents, characterization tools, and testing – all required to tackle the bottlenecks of gene therapy commercialization.
Our Gene Therapy Process Development Services allow you to:
Leveraging our in-house expertise, we offer a complete range of process development (PD) services to improve yield and quality of your viral vectors. Our PD capabilities include different upstream bioprocessing and downstream purification approaches involving various virus types and diverse modes of adherent or suspension cultures. The breadth of our experience allows us to develop robust production processes to move your gene therapy products quickly through clinical trials and to commercialization.
We have established a full tech transfer team to ensure successful knowledge transfer and scaling-up of developed production/purification processes for cGMP manufacturing. The tech transfer team delineates acceptance criteria for engineering and cGMP programs, working collaboratively with our manufacturing team and clients. We have averaged more than twenty new tech transfer projects annually and have helped clients achieve faster speed-to-market.
To learn more about our Process Development Services for gene therapy manufacturing, contact us today.
Article: Three Cost Modeling Insights to Reduce Gene Therapy Manufacturing Cost
Article: Avoid Costly Process Development Mistakes
Article: Avoiding Costly and Time-consuming Mistakes in Gene Therapy Process Development
Article: Considerations for Bioreactor Process Development and Scale-up for Transient Transfection-based Lentivirus Production in Suspension
Article: Considerations for Development of a Platform Lentivirus Harvest Clarification Process for Cell and Gene Therapy